Co-Diagnostics, Inc. Common Stock (CODX) is a publicly traded Healthcare sector company. As of September 1, 2026, CODX trades at $1.18 with a market cap of $8.45M and a P/E ratio of -0.03. CODX moved -4.03% today. Year to date, CODX is -75.48%; over the trailing twelve months it is -87.46%. Its 52-week range spans $0.94 to $46.50. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces CODX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CODX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $1.18 |
| Market Cap | $8.45M |
| P/E Ratio | -0.03 |
| EPS | $-39.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.50 |
| 52-Week Low | $0.94 |
| Volume | 121.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $721.39K |
| Net Income | $-47.06M |
| Gross Margin | 43.48% |
1 analysts cover CODX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.